Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

99 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The effect of oxygen saturation targeting on retinal blood vessel growth using retinal image data from the BOOST-II UK Trial.
Moreton RB, Fleck BW, Fielder AR, Williams CA, Butler L, Wilson C, Cocker K, Juszczak E, King A, Stenson B, Brocklehurst P; BOOST-II UK Collaborative Group. Moreton RB, et al. Among authors: fleck bw. Eye (Lond). 2016 Apr;30(4):577-81. doi: 10.1038/eye.2015.280. Epub 2016 Jan 22. Eye (Lond). 2016. PMID: 26795413 Free PMC article. Clinical Trial.
An international comparison of retinopathy of prematurity grading performance within the Benefits of Oxygen Saturation Targeting II trials.
Fleck BW, Williams C, Juszczak E, Cocker K, Stenson BJ, Darlow BA, Dai S, Gole GA, Quinn GE, Wallace DK, Ells A, Carden S, Butler L, Clark D, Elder J, Wilson C, Biswas S, Shafiq A, King A, Brocklehurst P, Fielder AR; BOOST II Retinal Image Digital Analysis (RIDA) Group. Fleck BW, et al. Eye (Lond). 2018 Jan;32(1):74-80. doi: 10.1038/eye.2017.150. Epub 2017 Jul 28. Eye (Lond). 2018. PMID: 28752837 Free PMC article. Clinical Trial.
Oxygen saturation and outcomes in preterm infants.
BOOST II United Kingdom Collaborative Group; BOOST II Australia Collaborative Group; BOOST II New Zealand Collaborative Group; Stenson BJ, Tarnow-Mordi WO, Darlow BA, Simes J, Juszczak E, Askie L, Battin M, Bowler U, Broadbent R, Cairns P, Davis PG, Deshpande S, Donoghoe M, Doyle L, Fleck BW, Ghadge A, Hague W, Halliday HL, Hewson M, King A, Kirby A, Marlow N, Meyer M, Morley C, Simmer K, Tin W, Wardle SP, Brocklehurst P. BOOST II United Kingdom Collaborative Group, et al. Among authors: fleck bw. N Engl J Med. 2013 May 30;368(22):2094-104. doi: 10.1056/NEJMoa1302298. Epub 2013 May 5. N Engl J Med. 2013. PMID: 23642047 Free article. Clinical Trial.
Transcutaneous oxygen levels in retinopathy of prematurity.
Cunningham S, Fleck BW, Elton RA, McIntosh N. Cunningham S, et al. Among authors: fleck bw. Lancet. 1995 Dec 2;346(8988):1464-5. doi: 10.1016/s0140-6736(95)92475-2. Lancet. 1995. PMID: 7490994 Clinical Trial.
Therapy for retinopathy of prematurity.
Fleck BW. Fleck BW. Lancet. 1999 Jan 16;353(9148):166-7. doi: 10.1016/S0140-6736(05)77211-1. Lancet. 1999. PMID: 9923868 No abstract available.
99 results